Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Plos One|September 17, 2014
Epidemiology and outcome of severe sepsis and septic shock in intensive care units in mainland ChinaJianfang Zhou, Chuanyun Qian, Mingyan Zhao, et al.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue|May 10, 2020
[Stratified outcomes of "Kidney Disease: Improving Global Outcomes" serum creatinine criteria in critical ill patients: a secondary analysis of a multicenter prospective study]Guiying Dong, Junping Qin, Youzhong An, et al.
Iscience|December 1, 2025
Development of DARPin T cell engagers for specific targeting of tumor-associated HLA/peptide complexesNatalia Venetz-Arenas, Tim Schulte, Sandra Müller, et al.
Renal Failure|December 3, 2021
Utilizing reclassification to explore characteristics and prognosis of KDIGOSCr AKI subgroups: a retrospective analysis of a multicenter prospective cohort studyGui-Ying Dong, Jun-Ping Qin, Youzhong An, et al.
Annals of Translational Medicine|September 27, 2016
Effectiveness of enteral feeding protocol on clinical outcomes in critically ill patients: a study protocol for before-and-after designZhongheng Zhang, Qian Li, Lingzhi Jiang, et al.
Critical Care Medicine|June 5, 2023
Efficacy and Safety of Ciprofol Sedation in ICU Patients Undergoing Mechanical Ventilation: A Multicenter, Single-Blind, Randomized, Noninferiority TrialYongjun Liu, Zhiyong Peng, Songqiao Liu, et al.
Intensive Care Medicine|March 31, 2026
Short-term light sedation with remimazolam besylate versus propofol in the ICU (SHOSREB): a multicentre, randomized, single-blind, controlled trialXiaobo Yang, Jingye Pan, Xun Gong, et al.
Plos One|August 4, 2017
Effectiveness of enteral feeding protocol on clinical outcomes in critically ill patients: A before and after studyQian Li, Zhongheng Zhang, Bo Xie, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 2, 2026
Design of solubly expressed miniaturized SMART MHCsWilliam L White, Hua Bai, Chan Jhong Kim, et al.
BMJ (Clinical Research Ed.)|January 15, 2025
The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trialJianfeng Wu, Fei Pei, Lixin Zhou, et al.
Pageof 10